EGLE Therapeutics Strengthens Its Board of Directors With the Appointment of Michel Detheux, Ph.D., as Independent Chairman Board Member, and With the Appointment of Mojgan Hossein-Nia, Ph.D. as Board Member Representative of Takeda Ventures
Press Release: Transgene Appoints Two Seasoned Leaders in Oncology to Drive Its Next Phase of Innovation
ITeos to Participate in Upcoming Investor Conferences
Express News | Iteos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 Galaxies Lung-201 Interim Data at the European Society for Medical Oncology Congress 2024
J.P. Morgan Sticks to Its Buy Rating for ITeos Therapeutics (ITOS)
Wells Fargo Initiates Coverage On ITeos Therapeutics With Overweight Rating, Announces Price Target of $31